Chromosomal translocations (CTs) are the most common type of structural chromosomal abnormalities in humans. CTs have been reported in several studies in the Arab world, but the frequency and spectrum of these translocations are not well characterized. The aim of this study is to conduct a systematic review to estimate the frequency and spectrum of CTs in the 22 Arab countries. Four literature databases were searched: PubMed, Science Direct, Scopus, and Web of Science, from the time of inception until July 2021. A combination of broad search terms was used to collect all possible CTs reported in the Arab world. In addition to the literature databases, all captured CTs were searched in three chromosomal rearrangement databases (Mitelman Database, CytoD 1.0 Database, and the Atlas of Genetics and Cytogenetics in Oncology and Hematology), along with PubMed and Google Scholar, to check whether the CTs are unique to the Arabs or shared between Arabs and non-Arabs. A total of 9,053 titles and abstracts were screened, of which 168 studies met our inclusion criteria, and 378 CTs were identified in 15 Arab countries, of which 57 CTs were unique to Arab patients. Approximately 89% of the identified CTs involved autosomal chromosomes. Three CTs, t(9;22), t(13;14), and t(14;18), showed the highest frequency, which were associated with hematological malignancies, recurrent pregnancy loss, and follicular lymphoma, respectively. Complex CTs were commonly reported among Arabs, with a total of 44 CTs, of which 12 were unique to Arabs. This is the first study to focus on the spectrum of CTs in the Arab world and compressively map the ethnic-specific CTs relevant to cancer. It seems that there is a distinctive genotype of Arabs with CTs, of which some manifested with unique clinical phenotypes. Although ethnic-specific CTs are highly relevant to disease mechanism, they are understudied and need to be thoroughly addressed.
Chromosomal translocations (CTs) are genetic abnormalities that involve an exchange of segments between chromosomes, leading to unusual structural chromosomal rearrangements (Roukos and Misteli 2014). The consequences associated with CTs depend on the location of the breaks, which can lead to fusion of genes, gene disruption, or gene dysregulation (Wilch and Morton 2018). CTs are the most common type of structural chromosomal abnormalities found in humans and are classified into two main types, reciprocal and Robertsonian translocations (Vasilevska et al. 2013). Reciprocal translocation involves an exchange of segments between two non-homologous chromosomes. In contrast, Robertsonian translocations usually involve acrocentric chromosomes, in which the entire chromosome attaches to another chromosome at the centromere (Wilch and Morton 2018). Both types of translocations can be presented in balanced and unbalanced states (Roukos and Misteli 2014; Vasilevska et al. 2013).
Balanced translocations are usually not associated with phenotypic consequences and may pass undetected through generations (Wilch and Morton 2018). Although the estimates vary, balanced reciprocal translocations occur in about one per 300–500 individuals, whereas balanced Robertsonian translocations are more frequent and occur in about one per 100 individuals (Wilch and Morton 2018; Priya et al. 2018). Moreover, balanced translocations have been associated with recurrent pregnancy loss. For example, among 2–5% of couples suffering from frequent miscarriages, one of the partners was found to be a carrier of a balanced translocation (Dutta et al. 2011; Sheth et al. 2013). On the other hand, unbalanced translocations are less common. Still, they could lead to significant clinical anomalies such as monosomy and trisomy, accounting for around 1% of developmental delay and intellectual disability cases (Weckselblatt et al. 2015). Further, unbalanced translocations detected in affected children could arise de novo or may be inherited from a parent carrying a balanced translocation (Weckselblatt et al. 2015).
CTs are clinically relevant as they play key roles in several human cancers and non-cancerous diseases with a de novo frequency of one in 2000 (Roukos and Misteli 2014). Chromosomal aberrations have long been considered a characteristic feature of neoplasia, where acquired CTs have been reported in more than 50,000 cases of different cancer types (Rowley 2001). In addition, there is compelling evidence that CTs play a critical role in the initial pathogenesis events of about 20% of cancers, although the exact mechanism is not fully understood (Forabosco et al. 2009). CTs are also used as decisive diagnostic indicators for detecting several clinical syndromes using molecular cytogenetic techniques (Mitelman et al. 2007). The development of fluorescence in situ hybridization (FISH), multicolor FISH, and comparative genomic hybridization (CGH) have enabled the specific detection of unique sequences, chromosomal regions, and entire chromosomes for the identification of numerous chromosomal abnormalities implicated in oncogenesis (Nowakowska and Bocian 2004).
Although the spectrum of variants causing single-gene disorders (Al-Sadeq et al. 2019; Doss et al. 2016; Khan et al. 2021; Mosaeilhy et al. 2017; Zaki et al. 2017; Zayed 2015a, 2015b, 2015c) and associated with multifactorial diseases (Abuhendi et al. 2019; Al-Thani et al. 2021; Alhababi and Zayed 2018; Jemmeih et al. 2022; Younes et al. 2020; Younes et al. 2021; Younes and Zayed 2019; Zayed 2016a; Alsamman and H., Zayed, H., 2022) were reviewed in the Arab countries, the spectrum and frequency of CTs among Arab countries and their relevance to diseases have not been reported yet. Therefore, this systematic review aimed to explore the spectrum of CTs in the Arab world and their association with diseases.
Materials and methods
Four databases were searched (PubMed, Science Direct, Scopus, and Web of Science) for all articles published in English from the time of inception until July 2021. Search terms were broad to capture all conducted studies; this includes “Chromosomal translocation,” in combination with each of the 22 Arab countries, for example, “Iraq AND chromosomal translocation.” In addition, relevant articles were screened for both titles and abstracts for their eligibility.
The studies included in this review were selected based on the following inclusion criteria: (i) published in peer-reviewed journals, (ii) conducted on Arab patients residing in Arab countries, (iii) contained data on Arab patients diagnosed with any CTs, (iv) contained data about the frequency of Arab patients with CTs, and (v) Arabs residing in only Arab countries. Articles were excluded if they did not meet the inclusion criteria. All citations were exported to Endnote version X9, and duplicated articles were removed.
Data extraction and analysis
The collected data was reviewed twice by HTZ and FTA; another layer of revision was done by the senior author HZ to ensure that the data had been captured correctly. The eligible articles were fully screened, and the data related to the CTs were extracted, including disease, country, type of CTs, patients’ karyotype, age, number of patients screened, clinical phenotypes, method of CTs detection, association with other genetic abnormalities, and presence of consanguinity. To gain a better understanding of the ethnic distributions of the captured CTs, and identify whether they are unique to Arab populations or shared with other ethnic groups, in addition to literature search, all captured CTs were searched in the following databases: Mitelman Database (https://mitelmandatabase.isb-cgc.org/search_menu), CytoD 1.0 Database (http://www.changbioscience.com/cytogenetics/cyto1.pl), the Atlas of Genetics and Cytogenetics in Oncology and Hematology (http://atlasgeneticsoncology.org/), PubMed, and Google Scholar.
The search strategy identified 9,110 citations, of which 9,053 remained after removing duplicates. A total of 8,756 citations were irrelevant and therefore excluded. After the abstract screening, 297 citations were thoroughly screened for the inclusion criteria as described in the Methods section. Of these, 168 studies were eligible and included in our systematic analysis (Fig. 1). All reported CTs in the analysis were checked through several chromosomal rearrangement databases, as indicated in the “Methods” section, to identify their clinical significance and determine whether they are unique to the Arab populations or not.
The frequency of CTs among Arabs and their clinical findings
The CTs and their clinical significance captured in our study are summarized in Table 1, Table 2, and Table S1. Our strategy identified Arab individuals with CTs in 15 out of the 22 Arab countries. No studies were captured in Bahrain, Comoros, Djibouti, Iraq, Mauritania, Somalia, and Yemen. The highest number of CTs was reported in Egypt (n = 93), followed by Tunisia (n = 69), Morocco (n = 46), Syria (n = 36), Saudi Arabia (n = 31), Oman (n = 29), Qatar (n = 22), Lebanon (n = 16), Jordan (n = 12), Kuwait (n = 11), Algeria (n = 6), Sudan (n = 3), and UAE (n = 2), while only one CT was reported in each of Libya and Palestine. A total of 378 CTs were reported in individuals belonging to the 15 Arab countries (Table S1), of which 57 CTs were unique to Arabs (i.e., reported in Arabs and not reported in any other ethnic groups) (Table 1), and 321 CTs were shared with other ethnic groups (Table S1). Of the 378 CTs, 190 (50.3%) were reciprocal including 27 de novo and 22 familial CTs, whereas 40 (10.6%) were Robertsonian including 12 de novo and eight familial CTs. Further, CTs frequency among Arabs showed males preponderance. All autosomal and sex chromosomes were involved in the captured CTs (Fig. 2). The majority (89.4%) of the CTs involved the autosomal chromosomes. Chromosomes 22, 9, 1, 21, 14, 3, 18, 8, and 12 were the most frequently involved chromosomes, while chromosome Y was the least involved. Three translocations showed the highest frequency among Arabs: (i) t(9;22) in Egypt, Jordan, Kuwait, Lebanon, Morocco, Oman, Qatar, Saudi Arabia, Syria, and Tunisia; (ii) t(13;14) in Egypt, Morocco, Oman, Qatar, Saudi Arabia, and Tunisia; and (iii) t(14;18) in Egypt, Jordan, Lebanon, Saudi Arabia, and Tunisia. There were only 16 autosome-sex CTs: t(X;1), t(X;3), t(X;6), t(X;9), t(X;10), t(X;13), t(X;14), t(X;16), t(X;17), t(X;18), t(X;20), t(X;9;22), t(X;Y), t(Y;10), t(Y;14), and t(Y;22), which were reported in Egypt, Jordan, Morocco, Oman, Qatar, Syria, and Tunisia (Fig. 2).
Clinical findings in Arab patients with CTs
The clinical phenotypes associated with the reported CTs among Arabs are one or more of the following: hematological malignancies (51.6%), recurrent pregnancy loss (RPL) (22.0%), birth defects and intellectual disabilities (12.4%), infertility and subfertility disorders (4.7%), soft tissue malignancy (2.8%), monosomies and trisomies (2.3%), neurological disorders (1.6%), disorders of sex development (0.8%), metabolic disorders (0.5%), and other disorders (0.8%) as shown in Fig. 3. Hematological malignancies such as acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), de novo acute myeloid leukemia (AML), multiple myeloma, and follicular lymphoma (FL) were the most reported malignancies among Arabs in Algeria, Egypt, Jordan, Kuwait, Lebanon, Morocco, Oman, Qatar, Saudi Arabia, Sudan, Syria, and Tunisia. Further, CTs related to recurrent pregnancy loss, birth defects, intellectual disabilities, monosomy, and trisomy syndromes were the most frequent disorders reported among patients from Egypt, Morocco, Oman, Saudi Arabia, and Tunisia (Table S1). Around 46% of the reciprocal translocations were reported in patients with malignancies, and 48% were associated with RPL, birth defects, and intellectual disability. In comparison, 80% of the Robertsonian translocations were reported in patients with RPL and intellectual and developmental disabilities (Table S1).
The clinical molecular diagnostics methods that were used to diagnose the CTs among Arab patients included FISH, karyotyping, multiplex PCR, RT-PCR, nested PCR, microarrays, immunophenotyping, western blot, northern blot, southern blot, immunohistochemistry, and comparative genomic hybridization (CGH) (Table S1).
The frequency of unique CTs and their associated phenotypes among Arabs
Among the 378 identified CTs, 57 (15%) were unique to the Arab populations. The uniqueness of these CTs to Arabs was confirmed by searching these variants in different databases, including Mitelman Database, CytoD 1.0 Database, the Atlas of Genetics and Cytogenetics in Oncology and Hematology, PubMed, and Google Scholar. The highest number of identified unique CTs was found in Egypt (n = 12), followed by Tunisia (n = 10); Syria (n = 8); Morocco (n = 8); Saudi Arabia (n = 7); Qatar, Oman, and Kuwait (n = 3); Jordan (n = 2); and Lebanon (n = 1) (Table 1, Fig. 2). All identified distinctive CTs were reported only once among Arabs. Further, 12 were complex translocations involving more than two chromosomes.
As for the associated phenotypes, 23 (40.0%) of the identified unique CTs were found in patients diagnosed with hematological and soft tissue malignancies, mainly CML, AML, and FL, while 21 (35.6%) were found in patients with RPL, 8 (13.6%) in those with birth defects and intellectual disabilities, and four (6.8%) in those with fertility disorders (Table 1). Further, most of these unique CTs were reciprocal (67.8%) and associated with various conditions, whereas only three were Robertsonian (5.1%) and associated with RPL and fertility disorders.
The frequency of complex CTs and their associated phenotypes among Arabs
Complex CTs involving more than two chromosomes were reported in 9 out of 15 Arab countries. As shown in Table 2, a total of 44 complex CTs were reported, of which 12 (27.3%) were unique to Arabs, and 32 (72.7%) were shared with other ethnicities. Tunisia had the highest number of reported complex CTs (n = 25), followed by Syria (n = 10), Kuwait, and Morocco (n = 2), while only one complex CT was reported in each of Algeria, Jordan, Lebanon, Oman, and Saudi Arabia. Among these complex CTs, 41 (93.2%) were associated with hematological malignancies, including CML (n = 35), AML (n = 3), and ALL and APL (n = 1). Further, 33 CTs involved three chromosomes (three-way CT), nine involved four chromosomes (four-way CT), and two involved five chromosomes (five-way CT). The t(4;9;22) and t(9;21;22) were the most frequently reported complex CTs in patients diagnosed with CML (n = 3 each) in Syria and Tunisia (Table 2, Fig. 4). Of note, 12 complex CTs were unique to the Arabs and not reported elsewhere.
Distinctive phenotypes of shared CTs among Arabs
Out of 321 captured shared CTs, seven were reported with distinctive clinical phenotypes in the Arab patients, while they were associated with other clinical phenotypes in other ethnic groups. An example of such CTs is t(14;18), reported in a patient with chronic hepatitis C virus (HCV) infection in Egypt (Roulland et al. 2014). However, in the literature, this CT was reported in association with FL in Europe and East Asia (Zhu et al. 2020; Leich et al. 2009). Another example is t(12;19)(q13;q13), which is commonly reported in AML cases, but in Tunisia, this CT was reported in a patient with premature ovarian failure (Ayed et al. 2014; Huret et al. 2003). Further, t(7;16)(p22.1;p11.2) was reported with a distinctive phenotype in Tunisia in a patient with autistic disorder. In the literature and CTs databases, translocations between chromosome 7 and 16 at various breaking points were reported in cancer cases such as fibromyxoid sarcoma and endometrial stromal sarcoma, but no report of autistic disorders was found (t(7;16) n.d). Additionally, the t(1;16)(q23;q13), reported in Egypt in a case of cerebro-oculo-facio-skeletal (COFS) syndrome (Temtamy et al. 1996), have been associated with different phenotypes in other ethnic groups, such as malignant peripheral nerve sheath tumors (MPNST) in Japan (Velagaleti et al. 2004). Also, the t(3;4)(q28;p16), reported in Tunisia in a case of RPL (Hajlaoui et al. 2018a), was found to be linked with oropharynx squamous cell carcinoma in other ethnic populations (t(3;4)(q28;p16) n.d).
To our knowledge, this is the first review in the Arab world to comprehensively and systematically analyze peer-reviewed published articles related to patients with CTs from Arab countries. In this review, we investigated the spectrum and frequency of CTs in the Arab world. We used broad selection criteria to capture all data related to CTs in the Arab world. Our search strategy identified 168 studies, with a total of 378 CTs reported in 15 out of the 22 Arab countries (Table S1). The involvement of chromosomes in translocations showed a random distribution, where all the autosomal and sex chromosomes were involved in translocations at least on one occasion. The highest frequency of CTs was reported in Egypt, Tunisia, Morocco, Syria, and Saudi Arabia (Fig. 4). The captured CTs were detected using different molecular diagnostic methods but mainly using banded karyotyping, FISH, or RT-PCR. More recent studies used CGH to uncover cryptic rearrangements in the patients (Gregori et al. 2007; Vissers et al. 2007).
The most common CTs reported among Arabs were t(9;22), t(13;14), and t(14;18) at a frequency of n = 29, n = 15, and n = 13, respectively. The reciprocal CT t(9;22), was most reported in studies from Egypt, Syria, and Tunisia. This CT, which generates the Philadelphia chromosome (Ph), is usually detected in more than 90% of patients with CML and occurs in 3–5% of children with ALL, 25% of adult ALL, and in around 2% of children with AML (Aplenc et al. 2011; Aricò et al. 2000; Kang et al. 2016). A study conducted in Brazil reported a prevalence of 90.3% of classic Ph CT among CML patients (Chauffaille et al. 2015). Among Arabs, this translocation was primarily associated with hematological malignancies, including CML (44.8%), ALL (41.4%), and AML (10.3%). Notably, a higher prevalence of ALL due to Ph chromosome was reported among Arabs, particularly in male children aged 4–12 years. Although not reported, this could be due to the high prevalence of consanguinity and endogamy among Arabs and the major gaps between the social classes in the Arab countries compared to other populations (Tadmouri et al. 2009). A previous study conducted in the UAE suggested that socioeconomic factors could contribute to the relatively higher frequency of ALL among children of subcontinental origin when compared to other ethnic groups. In addition, the study indicated that parental consanguinity is significantly associated with the diagnosis of lymphomas among children (Révész et al. 1997; Révész et al. 1996).
Moreover, the Robertsonian CT, t(13;14), was the second most common CT reported among Arabs, showing the highest frequency in patients from Egypt (n = 5), Morocco (n = 4), and Tunisia (n = 3) (Fig. 4) with clinical phenotypes of RPL (n = 8) and fertility disorders (n = 4). This translocation is one of the most common Robertsonian CTs reported worldwide in which carriers usually show normal phenotypes, but male carriers can have infertility problems associated with oligospermia (Choi et al. 2013; Mahjoub et al. 2011). Female carriers of the karyotype 45,XX,t(13;14)(q10;q10) were reported to be at risk for developing reproductive problems, including miscarriage and infertility (Choi et al. 2013). A study conducted in Belgium reported a 66.7% prevalence of t(13;14) among Robertsonian CT carriers (Keymolen et al. 2011). In Poland, a cohort of 101 pedigrees of t(13;14) carriers was screened for clinical outcomes and showed a high frequency of recurrent miscarriage (34.7%) (Engels et al. 2008). However, no evidence of increased infertility rates among male and female carriers was found. Further, reports of this CT in children are scarce where only a single study conducted in Russia reported the occurrence of this CT in a child with developmental delay due to maternal inheritance (Dolskiy et al. 2018). Nevertheless, in this review, three children with Turner syndrome, Down syndrome, and intellectual disabilities were reported to have this CT in Egypt and Morocco (Mokhtar et al. 2003; Belkady et al. 2018; Latrech et al. 2018).
The t(14;18)(q32;21) was most frequently reported in patients with FL and diffuse large B-cell lymphoma. This reciprocal CT is considered a hallmark for FL and a recurrent abnormality in other types of non-Hodgkin lymphoma (NHL) (Rabkin et al. 2008). Further, the t(14;18) is frequently detected in the peripheral blood and tissue samples of healthy individuals, but the clinical significance is still unclear (Schüler et al. 2003). Additionally, the t(14;18)(q32;q21) is rarely associated with CLL and reported in less than 2% of CLL patients (Chen et al. 2016). Among Arabs, this CT was reported in a study conducted in Lebanon on a CLL Arab patient (Haddad et al. 2021). Tang et al. proposed that t(14;18)(q32;q21) could be an early pathogenetic event in CLL cases and may represent a secondary aberration that is not necessarily responsible for the disease onset since several CLL patients acquire novel abnormalities during the course of disease (Chen et al. 2016; Tang et al. 2013; Put et al. 2009; Shanafelt et al. 2006). Interestingly, two forms of this CT, t(14;18)(q13:p22) and t(14;18)(q21:p11), were reported in two females with RPL in Tunisia (Ayed et al. 2017b). A similar clinical phenotype was reported in only one study conducted in Japan on couples with two or more consecutive miscarriages, and hence, the exact involvement of t(14;18) in these cases remains unclear (Otani et al. 2006).
Among the identified CTs, 57 were distinctive to the Arab populations (Table 1) and were not previously reported in any study or database (Al-Achkar et al. 2013b, 2013c; Asif et al. 2016). All these CTs were reported once among Arabs, and hence, no frequent CTs were found in the Arab world. Interestingly, the t(21;21)(p11;p11) was the only CT reported with two different clinical phenotypes based on the type of translocation: intellectual disability when reciprocal and spontaneous RPL when Robertsonian (Belkady et al. 2018; Elkarhat et al. 2019). Both CTs were reported in 21-year retrospective studies conducted in Morocco on patients with intellectual disabilities and couples with recurrent spontaneous miscarriage, respectively.
Most of the unique CTs were identified in Egypt, which were mostly cases of RPL. Consanguinity was reported in only five cases (Elhady et al. 2020; AbouEl-Ella et al. 2018). However, it is most likely that consanguinity is underreported in these cases and could possibly be a significant contributor in RPL. Indeed, several studies conducted in Arab countries and non-Arab countries reported higher chances of miscarriage among consanguineous couples (Bellad et al. 2012; Saad and Jauniaux 2002; Gowri et al. 2011). The estimated prevalence of RPL is around 1–5% in married couples worldwide, where several etiological factors are involved, including parental chromosomal abnormalities (2–5%), anatomical alterations (10–15%), infections (0.5–5%), endocrinological disorders (17–20%), and immunological factors (20%) (Issa et al. 2021; Arias-Sosa et al. 2018). Nevertheless, in many cases, routine gynecological and laboratory investigations fail to identify the underlying cause of RPL. Hence, among the possible causes, CTs could be one of the etiological factors underlying RPL. Unfortunately, due to the growing cultural and religious sensitivity and controversy over reproductive health issues, this area remains relatively unexplored in Egypt. In addition, of the 57 unique CTs, 23 were detected in patients who presented with hematological malignancies and solid tumors, mainly in Syria and Tunisia (Table 1, Fig. 4). Previous studies reported that Syria had the highest incidence of leukemia at the national level in 2007 (Dong et al. 2020). This could be attributed to the unique CTs that have not been thoroughly investigated yet.
Complex CTs, which involve more than two breakpoints on two or more chromosomes, are not very common. However, among Arabs, complex CTs were reported in 11.6% of all identified CTs, mainly in Tunisia (56%) and Syria (23%), where chromosomes 9 and 22 were involved in 20 complex CTs. This CT was also reported in CML patients with complex variant translocations involving other chromosomes in addition to chromosomes 9 and 22 (Asif, et al. 2016; Manabe et al. 2011). However, such cases are not frequent and can be found in about 5–8% of CML cases (Manabe et al. 2011). Some studies have suggested that patients with variant Ph translocations may have an adverse prognosis (Gorusu et al. 2007; Potter et al. 1981; Loncarevic et al. 2002; Reid et al. 2003; Bernstein et al. 1984), while others suggested that these CTs have no prognostic effect (Bernstein et al. 1984; Marzocchi et al. 2011). Therefore, their impact on the prognosis and treatment response in CML patients is not conclusive. Notably, 12 complex CTs were not reported in the literature or any searched databases. Among these unique CTs, our search identified three-way, four-way, and five-way CTs, most of which involving the Ph chromosome and associated with CML and AML (Al-Achkar, et al. 2013c, 2007b; Kamal et al. 1996b; Adriana and Al Bahar 2012b; Achkar et al. 2010; Bennour et al. 2009b), except for one complex CT that was reported in a patient with a history of 12 miscarriages in Saudi Arabia (Turki et al. 2016b). Four-way CTs are rare, with less than 60 cases reported in the literature (Asif, et al. 2016). Similarly, five-way CTs are very rare in CML patients, with only a few cases reported (Yokota et al. 2012). Our search identified nine different four-way CTs, of which three were unique to Arabs and two five-way CTs, both of which were reported in CML cases in Syria and Tunisia and found to be unique to the Arab populations (Bennour et al. 2009b; Al Achkar et al. 2009b).
The findings of distinctive CTs and complex CTs could be due to the unique genomic architecture of Arabs (Zayed 2016b, 2016c), which is not well represented in the genomic databases. This emphasizes on the importance of such studies on the healthcare of Arab patients with CTs.
Finally, we investigated the clinical phenotypes of the shared CTs between Arabs and other ethnic groups; we further classified them as common or unique. We found that seven Arab patients seem to have manifested distinctive clinical phenotypes, mainly in Egypt and Tunisia. Nevertheless, no clear correlation between these CTs and the associated phenotypes was identified, which mandates further investigation to highlight the significance of these findings.
Some limitations were encountered in our study: first, the lack of detailed clinical data about the patients as most of the captured studies did not report some key data about the translocations, making it difficult to compare the different studies from different countries and identify other confounding factors that might be associated with the captured cases. Second, the variations in studies included in this review made it challenging to identify a general prevalence trend among Arab countries of CTs. Third, the lack of cytogenetics and molecular analyses in some studies; and fourth, variations in the detection methods used to capture the CTs, which could have affected the accuracy of the results in terms of identifying the exact breakpoints in the CTs. For instance, PCR-based detection was reported to be less sensitive than FISH analysis due to its inability to detect all breakpoint variants in CTs (Gomez et al. 2005). Therefore, a standard method of detection could help in improving the detection and diagnosis of CTs.
This study addresses something that is not adequately reported, which is the ethnic CTs and their high relevance to cancer. This is the first systematic review to study the frequency and spectrum of CTs in the Arab region. In this study, 168 studies reported a total of 378 CTs in 15 Arab countries. We found distinctive CTs susceptibility profile to cancer and unique complex CTs that were found only among Arab populations (not existing in different ethnic groups); these are important for disease prognosis and diagnosis. This comprehensive study is important to highlight the health disparities that may exist within the Arab populations. Further, this work marks an important starting point for future studies focused on the etiology of CTs and highlights several hurdles within the Arab populations that will have to be overcome by further studies. This includes more openness and less stigma around issues such as reproductive health, consanguinity, and endogamy.
Abdallah IB et al (2011) Chromosomal microarray analysis in a girl with mental retardation and spina bifida. Pediatr Neurol 44(1):65–68
AbouEl-Ella SS et al (2018) Study of congenital malformations in infants and children in Menoufia governorate. Egypt Egyptian J Med Hum Genet 19(4):359–365
Abuhendi N et al (2019) Genetic polymorphisms associated with type 2 diabetes in the Arab world: a systematic review and meta-analysis. Diabetes Res Clin Pract 151:198–208
Achkar WA et al (2010) A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes. Oncol Lett 1(5):797–800
Adriana Z, Al Bahar S (2012) Novel four-way Ph translocation t (9; 22; 7; 1)(q34; q11; q22; p13) in a chronic myeloid leukemia patient receiving tyrosine kinase inhibitor therapy. Int J Hematol 95(3):315–319
Adriana Z, Al Bahar S (2012) Novel four-way Ph translocation t(9;22;7;1)(q34;q11;q22;p13) in a chronic myeloid leukemia patient receiving tyrosine kinase inhibitor therapy. Int J Hematol 95(3):315–9
Al Achkar W et al (2009) Novel complex translocation involving 5 different chromosomes in a chronic myeloid leukemia with Philadelphia chromosome: a case report. Mol Cytogenet 2:21
Al Achkar W et al (2009) Novel complex translocation involving 5 different chromosomes in a chronic myeloid leukemia with Philadelphia chromosome: a case report. Mol Cytogenet 2:4
Al Achkar W et al (2010) A rare case of chronic myeloid leukemia with secondary chromosomal changes including partial trisomy 17q21 to 17qter and partial monosomy of 16p13. 3. Mol Cytogenet 3(1):1–4
Al Achkar W et al (2010) A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes. Oncol Lett 1(5):797–800
Al Achkar W et al (2010) A unique complex translocation involving six different chromosomes in a case of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and adverse prognosis. Oncol Lett 1(5):801–804
Al-Achkar W, Wafa A, Nweder M (2007) A complex translocation t (5; 9; 22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia. J Exp Clin Cancer Res 26(3):411–415
Al-Achkar W, Wafa A, Nweder MS (2007) A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia. J Exp Clin Cancer Res 26(3):411–415
Al-Achkar W, Wafa A, Almedani S (2010) BCR translocation to derivative chromosome 2: a new case of chronic myeloid leukemia with a complex variant translocation and Philadelphia chromosome. Oncol Lett 1(3):445–447
Al-Achkar W, Wafa A, Liehr T (2011) Complex translocation involving four chromosomes in a novel Philadelphia-positive chronic myeloid leukemia case. Oncol Lett 2(2):273–276
Al-Achkar W et al (2012) A chronic myeloid leukemia case with a unique variant Philadelphia translocation: t (9; 22; 21)(q34; q11; p12). Oncol Lett 3(5):1027–1029
Al-Achkar W, Wafa A, Liehr T (2013) A new t (9; 11; 20; 22)(q34; p11. 2; q11. 21; q11) in a Philadelphia-positive chronic myeloid leukemia case. Oncol Lett 5(2):605–608
Al-Achkar W et al (2013) A novel cytogenetic abnormality t(7;8)(p11.2:q11.2) and a four-way Philadelphia translocation in an imatinib mesylate-resistant chronic myeloid leukemia patient. Oncol Lett 5(2):617–620
Al-Achkar W et al (2013) Three-way Philadelphia translocation t(9;10;22)(q34;p11.2;q11.2) as a secondary abnormality in an imatinib mesylate-resistant chronic myeloid leukemia patient. Oncol Lett 5(5):1656–1658
Al‐Achkar W, Wafa A, Jarjour RA (2011) A new case of de novo translocation (12; 17; 18)(q21. 2; q22; q21. 1) and cranio‐cerebello‐cardiac (3C) syndrome. Am J Med Genet Part A 155(3):648–651
Al‑Achkar W et al (2013) Three‑way Philadelphia translocation t (9; 10; 22)(q34; p11. 2; q11. 2) as a secondary abnormality in an imatinib mesylate‑resistant chronic myeloid leukemia patient. Oncol Lett 5(5):1656–1658
Alhababi D, Zayed H (2018) Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries. Atherosclerosis 279:62–72
Alhashem AM et al (2020) Intellectual disability in two brothers caused by de novo novel unbalanced translocation (13; 18)(q34, q23) and de novo microdeletion 6q25 syndrome. Cureus 12(1).
Aljabry M (2015) Complex karyotype with novel translocation in pure erythroid leukemia patient. Hematol Rep 7(1).
AlMajhad NA et al (2017) Neurological expression of an inherited translocation of chromosomal 1 and 7. Neurosci J 22(1):62–64
Al-Sadeq D et al (2019) Spectrum of mutations of cystic fibrosis in the 22 Arab countries: a systematic review. Respirology 24(2):127–136
Alsamman AM, A H, Zayed H (2022) Whole-genome sequencing of 100 genomes identifies a distinctive genetic susceptibility profile of Qatari patients with hypertension. J Personalized Med 12(5):722.
Al-Thani HF et al (2021) Genetic variants associated with Alzheimer disease in the 22 Arab countries: a systematic review. Alzheimer Dis Assoc Disord 35(2):178–186
El Andaloussi A, and Bilhou-Nabera C (2007) New complex chromosomal translocation in chronic myeloid leukaemia: T (9; 18; 22)(q34; p11; q11). J Biomed Biotechnol.
Aplenc R, Lipsitz EG, Adamson PC (2011) CHAPTER 15 - Oncology. In: Polin RA, Ditmar MF (eds) Pediatric Secrets (Fifth Edition). Mosby, Philadelphia, pp 584–613
Arafa MM et al (2018) Chromosomal abnormalities in infertile men with azoospermia and severe oligozoospermia in Qatar and their association with sperm retrieval intracytoplasmic sperm injection outcomes. Arab J Urol 16(1):132–139
Arias-Sosa LA et al (2018) Genetic and epigenetic variations associated with idiopathic recurrent pregnancy loss. J Assist Reprod Genet 35(3):355–366
Aricò M et al (2000) Outcome of treatment in children with philadelphia chromosome–positive acute lymphoblastic leukemia. N Engl J Med 342(14):998–1006
Asif M et al (2016) A novel four-way complex variant translocation involving chromosome 46,XY,t(4;9;19;22)(q25:q34;p13.3;q11.2) in a chronic myeloid leukemia patient. Front Oncol 6:124
Ayed W et al (2014) Cytogenetic abnormalities in Tunisian women with premature ovarian failure. CR Biol 337(12):691–694
Ayed W et al (2017) Chromosomal abnormalities in 163 Tunisian couples with recurrent miscarriages. Pan African Medical Journal 28(1):158
Ayed W et al (2017) Chromosomal abnormalities in 163 Tunisian couples with recurrent miscarriages. Pan Afr Med J 28:99
Belkady B et al (2018) Chromosomal abnormalities in patients with intellectual disability: a 21-year retrospective study. Hum Hered 83(5):274–282
Bellad MB et al (2012) Consanguinity, prematurity, birth weight and pregnancy loss: a prospective cohort study at four primary health center areas of Karnataka. India J Perinatol 32(6):431–437
Bennour A et al (2009) Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9. Cancer Genet Cytogenet 194(1):30–37
Bennour A et al (2013) A PML/RARA chimeric gene on chromosome 12 in a patient with acute promyelocytic leukemia (M4) associated with a new variant translocation: t (12; 15; 17)(q24; q24; q11). Med Oncol 30(1):1–5
Bennour A et al (2010) TRANSLOCATION (X; 10)(P10; P10): A rare but non random chromosomal abnormality in acute myeloid leukemia. in Haematologica-the Hematology Journal. Ferrata Storti Foundation via Giuseppe Belli 4, 27100 Pavia, Italy.
Bernstein R et al (1984) The incidence, type, and subsequent evolution of 14 variant Ph1 translocations in 180 South African patients with Ph1-positive chronic myeloid leukemia. Cancer Genet Cytogenet 12(3):225–238
Chauffaille MdLLF, Bandeira ACdA, and da Silva ASG (2015) Diversity of breakpoints of variant Philadelphia chromosomes in chronic myeloid leukemia in Brazilian patients. Revista brasileira de hematologia e hemoterapia 37(1): 17–20.
Chen W et al (2016) t(14;18)(q32;q21) in chronic lymphocytic leukemia patients: report of two cases and a literature review. Oncol Lett 12(6):4351–4356
Cherian MP (2012) Influence of HLA DQ 2/8 genotypes in predisposing type 1 diabetes in siblings of a Saudi family with paternally inherited chromosomal translocations. J Pediatr Endocrinol Metab 25(5–6):569–572
Choi BH et al (2013) Various endocrine disorders in children with t(13;14)(q10;q10) Robertsonian translocation. Ann Pediatr Endocrinol Metab 18(3):111–115
De Gregori M et al (2007) Cryptic deletions are a common finding in “balanced” reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet 44(12):750–762
Diejomaoh MF et al (2015) Consecutive successful pregnancies subsequent to intravenous immunoglobulin therapy in a patient with recurrent spontaneous miscarriage. Int Med Case Reports J 8:337
Dolskiy AA et al (2018) Robertsonian translocation 13/14 associated with rRNA genes overexpression and intellectual disability. Egypt J Med Hum Genet 19(2):141–145
Dong Y et al (2020) Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol 9(1):14
Doss CG et al (2016) Genetic epidemiology of glucose-6-phosphate dehydrogenase deficiency in the Arab world. Sci Rep 6:37284
Dutta UR et al (2011) Cytogenetic abnormalities in 1162 couples with recurrent miscarriages in southern region of India: report and review. J Assist Reprod Genet 28(2):145–149
El-Dahtory FAM (2011) Chromosomal abnormalities as a cause of recurrent abortions in Egypt. Indian J Hum Genet 17(2):82
Elhady GM, Kholeif S, Nazmy N (2020) Chromosomal aberrations in 224 couples with recurrent pregnancy loss. J Human Reproductive Sci 13(4):340
Elkarhat Z et al (2019) Chromosomal abnormalities in couples with recurrent spontaneous miscarriage: a 21-year retrospective study, a report of a novel insertion, and a literature review. J Assist Reprod Genet 36(3):499–507
El-Ruby M, Hemly N, Zaki MS (2007) Maternal balanced translocation (4; 21) leading to an offspring with partial duplication of 4q and 21q without phenotypic manifestations of Down syndrome. Genet Couns 18(2):217
Engels H et al (2008) Genetic counseling in Robertsonian translocations der(13;14): frequencies of reproductive outcomes and infertility in 101 pedigrees. Am J Med Genet A 146A(20):2611–2616
Farra C et al (2004) Complex translocation (8; 12; 21): a new variant of t (8; 21) in acute myeloid leukemia. Cancer Genet Cytogenet 155(2):138–142
Forabosco A, Percesepe A, Santucci S (2009) Incidence of non-age-dependent chromosomal abnormalities: a population-based study on 88965 amniocenteses. Eur J Hum Genet 17(7):897–903
Gaboon NE et al (2015) Structural chromosomal abnormalities in couples with recurrent abortion in Egypt. Turk J Med Sci 45(1):208–213
Gomez M, Wu X, Wang YL (2005) Detection of BCL2-IGH using single-round PCR assays. Diagn Mol Pathol 14(1):17–22
Gorusu M et al (2007) On the genesis and prognosis of variant translocations in chronic myeloid leukemia. Cancer Genet Cytogenet 173(2):97–106
Goud TM et al (2009) Cytogenetic studies in couples with recurrent miscarriage in the Sultanate of Oman. Reprod Biomed Online 18(3):424–429
Goud TM et al (2015) Importance of FISH combined with morphology, immunophenotype and cytogenetic analysis of childhood/ adult acute lymphoblastic leukemia in Omani patients. Asian Pac J Cancer Prev 16(16):7343–7350
Gowri V et al (2011) Recurrent early pregnancy loss and consanguinity in Omani couples. Acta Obstet Gynecol Scand 90(10):1167–1169
Haddad FG et al (2021) An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinib. Leukemia Res Rep 15:100245
Hajlaoui A et al (2018) Subtelomeric rearrangements in patients with recurrent miscarriage. Int J Fertil Steril 12(3):218
Hajlaoui A et al (2018) Sperm fluorescent in situ hybridisation study of interchromosomal effect in six Tunisian carriers of reciprocal and Robertsonian translocations. Andrologia 50(4):e12949
Huret JL, Dessen P, Bernheim A (2003) Atlas of Genetics and Cytogenetics in Oncology and Haematology. Nucleic Acids Res 31(1):272–4. https://doi.org/10.1093/nar/gkg126
Issa NM et al (2021) The prevalence of specific gene polymorphisms related to thrombophilia in Egyptian women with recurrent pregnancy loss. J Hum Reprod Sci 14(1):73–80
Jemmeih S et al (2022) Genetic epidemiology of primary congenital glaucoma in the 22 Arab Countries: a systematic review. Ophthalmic Epidemiol 29(1):1–12
Kamal NR, Hanson CA, Dewald GW (1996) Acute promyelocytic leukemia with t (15; 16; 17; 19) and unusual fluorescence in situ hybridization pattern with PML and RARA probes. Cancer Genet Cytogenet 92(1):54–57
Kamal NR, Hanson CA, Dewald GW (1996) Acute promyelocytic leukemia with t(15;16;17;19) and unusual fluorescence in situ hybridization pattern with PML and RARA probes. Cancer Genet Cytogenet 92(1):54–57
Kang Z-J et al (2016) The Philadelphia chromosome in leukemogenesis. Chin J Cancer 35:48–48
Keymolen K et al (2011) Pregnancy outcome in carriers of Robertsonian translocations. Am J Med Genet A 155(10):2381–2385
Khalifa OA et al (2011) Terminal 4q deletion and 8q duplication in a patient with CHARGE-like features. Eur J Med Genet 54(2):173–176
Khan AM et al (2021) The spectrum of beta-thalassemia mutations in the 22 Arab countries: a systematic review. Expert Rev Hematol 14(1):109–122
Latrech H, Madar H, Gaouzi A (2018) Combination of gonadal dysgenesis and monosomy X with a novo translocation (13,14). Case Rep Endocrinol 2018:3796415
Leich E et al (2009) Follicular lymphomas with and without translocation t (14; 18) differ in gene expression profiles and genetic alterations. Blood J Am Soc Hematol 114(4):826–834
Loncarevic IF et al (2002) Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia. Genes Chromosomes Cancer 34(2):193–200
Mahjoub M et al (2011) Chromosomal segregation in spermatozoa of five Robertsonian translocation carriers t (13; 14). J Assist Reprod Genet 28(7):607–613
Manabe M et al (2011) A Rare t(9;22;16)(q34;q11;q24) Translocation in chronic myeloid leukemia for which imatinib mesylate was effective: a case report. Leuk Res Treatment 2011:592519
Marzocchi G et al (2011) Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. Blood J Am Soc Hematol 117(25):6793–6800
Masri A et al (2014) Microarray delineation of familial chromosomal imbalance with deletion 5q35 and duplication 10q25 in a child showing multiple anomalies and dysmorphism. Am J Med Genet A 164(5):1254–1261
Mitelman F, Johansson B, Mertens F (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7(4):233–245
Mokhtar MM et al (2003) Cytogenetic profile of Down syndrome in Alexandria. Egypt East Mediterr Health J 9(1–2):37–44
Mosad E, Abdou M, Zaky AH (2012) Rearrangement of the myeloid/lymphoid leukemia gene in therapy-related myelodysplastic syndrome in patients previously treated with agents targeting DNA topoisomerase II. Oncology 83(3):128–134
Mosaeilhy A et al (2017) Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I. Metab Brain Dis 32(5):1417–1426
Nowakowska B, Bocian E (2004) Molecular cytogenetic techniques and their application in clinical diagnosis. Med Wieku Rozwoj 8(1):7–24
Otani T et al (2006) Preimplantation genetic diagnosis significantly improves the pregnancy outcome of translocation carriers with a history of recurrent miscarriage and unsuccessful pregnancies. Reprod Biomed Online 13(6):869–874
Philip T et al (1981) EBV-positive Burkitt’s lymphoma from algeria, with a three-way rearrangement involving chromosomes 2, 8 and 9. Int J Cancer 28(4):417–420
Potter AM et al (1981) Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukaemia. Br J Cancer 44(1):51–54
Priya PK et al (2018) A study on balanced chromosomal translocations in couples with recurrent pregnancy loss. J Human Reprod Sci 11(4):337–342
Put N et al (2009) Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia. Leukemia 23(6):1201–1204
Rabkin CS et al (2008) t(14;18) Translocations and risk of follicular lymphoma. J Natl Cancer Inst Monogr 39:48–51
Reid AG et al (2003) Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia. Br J Haematol 121(3):419–427
Révész T, Pramathan T, Mpofu C (1996) Leukaemia phenotype and ethnicity in children living in the United Arab Emirates. Haematologia (budap) 28(1):9–12
Révész T et al (1997) Socioeconomic factors in the families of children with lymphoid malignancy in the UAE. Leukemia 11(4):588–593
Roukos V, Misteli T (2014) The biogenesis of chromosome translocations. Nat Cell Biol 16(4):293–300
Roulland S et al (2014) t (14; 18) Translocation: a predictive blood biomarker for follicular lymphoma. J Clin Oncol 32(13):1347–1355
Rowley JD (2001) Chromosome translocations: dangerous liaisons revisited. Nat Rev Cancer 1(3):245–250
Saad FA, Jauniaux E (2002) Recurrent early pregnancy loss and consanguinity. Reprod Biomed Online 5(2):167–170
Schüler F, Hirt C, Dölken G (2003) Chromosomal translocation t(14;18) in healthy individuals. Semin Cancer Biol 13(3):203–209
Shanafelt TD et al (2006) Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 24(28):4634–4641
Sheth FJ et al (2013) Chromosomal abnormalities in couples with repeated fetal loss: an Indian retrospective study. Indian J Hum Genet 19(4):415–422
t(3;4)(q28;p16). Atlas of Genetics and Cytogenetics in Oncology and Haematology: Atlas of Genetics and Cytogenetics in Oncology and Haematology.
t(7;16). Cytogenetics Database CytoD 1.0.
Tadmouri GO et al (2009) Consanguinity and reproductive health among Arabs. Reprod Health 6(1):17
Tang G et al (2013) Chronic lymphocytic leukemia with t(14;18)(q32;q21). Hum Pathol 44(4):598–605
Temtamy S et al (1996) COFS syndrome with familial 1; 16 translocation. Clin Genet 50(4):240–243
Turki RF et al (2016) Associations of recurrent miscarriages with chromosomal abnormalities, thrombophilia allelic polymorphisms and/or consanguinity in Saudi Arabia. BMC Med Genet 17(1):15–23
Turki RF et al (2016) Associations of recurrent miscarriages with chromosomal abnormalities, thrombophilia allelic polymorphisms and/or consanguinity in Saudi Arabia. BMC Med Genet 17(Suppl 1):69
Udayakumar AM et al (2008) Complex t (8; 13; 21)(q22; q14; q22)–a novel variant of t (8; 21) in a patient with acute myeloid leukemia (AML–M2). Arch Med Res 39(2):252–256
Vasilevska M et al (2013) The incidence and type of chromosomal translocations from prenatal diagnosis of 3800 patients in the republic of macedonia. Balkan J Med Genet 16(2):23–28
Velagaleti GVN, Miettinen M, Gatalica Z (2004) Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation (malignant triton tumor) with balanced t(7;9)(q11.2;p24) and unbalanced translocation der(16)t(1;16)(q23;q13). Cancer Genet Cytogenet 149(1):23–27
Vissers LE et al (2007) Complex chromosome 17p rearrangements associated with low-copy repeats in two patients with congenital anomalies. Hum Genet 121(6):697–709
Wafa A et al (2016) A high complex karyotype involving eleven chromosomes including three novel chromosomal aberrations and monoallelic loss of TP53 in case of follicular lymphoma transformed into B-cell lymphoblastic leukemia. Mol Cytogenet 9(1):1–7
Wafa A et al (2016) Acute promyelocytic leukemia with the translocation t (15; 17)(q22; q21) associated with t (1; 2)(q42~ 43; q11. 2~ 12): a case report. J Med Case Rep 10(1):1–5
Weckselblatt B, Hermetz KE, Rudd MK (2015) Unbalanced translocations arise from diverse mutational mechanisms including chromothripsis. Genome Res 25(7):937–947
Wilch ES, Morton CC (2018) Historical and clinical perspectives on chromosomal translocations. Adv Exp Med Biol 1044:1–14
Yamada O et al (2014) Emergence of a BCR-ABL translocation in a patient with the JAK2V617F mutation: evidence for secondary acquisition of BCR-ABL in the JAK2V617F clone. J Clin Oncol: Off J Am Soc Clin Onc 32(21):e76–e79
Yokota S, Nakamura Y, Bessho M (2012) A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report. Mol Cytogenet 5(1):20
Younes N, Zayed H (2019) Genetic epidemiology of ovarian cancer in the 22 Arab countries: a systematic review. Gene 684:154–164
Younes N et al (2020) Immunogenetics of celiac disease: a focus on arab countries. Curr Mol Med 20(4):275–285
Younes S et al (2021) Genetic polymorphisms associated with obesity in the Arab world: a systematic review. Int J Obes (lond) 45(9):1899–1913
Zahed L et al (2004) Ring chromosome 18q and jumping translocation 18p in an adult male with hypergonadotrophic hypogonadism. Am J Med Genet A 129(1):25–28
Zaki OK et al (2017) Two patients with Canavan disease and structural modeling of a novel mutation. Metab Brain Dis 32(1):171–177
Zámecˇníkova A, Al Bahar S, Pandita R (2012) Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient. Hematology 17(6):321–324
Zayed H (2015) Propionic acidemia in the Arab world. Gene 564(2):119–124
Zayed H (2015) Krabbe Disease in the Arab world. J Pediatr Genet 4(1):1–8
Zayed H (2015) Canavan disease: an Arab scenario. Gene 560(1):9–14
Zayed H (2016) Genetic epidemiology of type 1 diabetes in the 22 Arab countries. Curr Diab Rep 16(5):37
Zayed H (2016) The Arab genome: health and wealth. Gene 592(2):239–243
Zayed H (2016) The Qatar genome project: translation of whole-genome sequencing into clinical practice. Int J Clin Pract 70(10):832–834
Zhu Z et al (2020) Molecular and clinical progress in follicular lymphoma lacking the t (14; 18) translocation. Int J Oncol 56(1):7–17
Open Access funding provided by the Qatar National Library.
Conflict of interest
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Zedan, H.T., Ali, F.H. & Zayed, H. The spectrum of chromosomal translocations in the Arab world: ethnic-specific chromosomal translocations and their relevance to diseases. Chromosoma 131, 127–146 (2022). https://doi.org/10.1007/s00412-022-00775-2